Maprotiline: a Review of Its Pharmacological Properties and Therapeutic Efficacy in Mental Depressive States

Overview

Journal Drugs

Specialty Pharmacology

Date 1977 May 1

PMID 326531

Citations 28

Authors

R M Pinder

R N Brogden

T M Speight

G S Avery

Affiliations

Soon will be listed here.

Citing Articles

Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.

Tian S, Xu M, Geng X, Fang J, Xu H, Xue X Adv Sci (Weinh). 2024; 12(1):e2410285.

PMID: 39499771 PMC: 11714211. DOI: 10.1002/advs.202410285.

Catalytic asymmetric [4 + 2] dearomative photocycloadditions of anthracene and its derivatives with alkenylazaarenes.

Tian D, Shi W, Sun X, Zhao X, Yin Y, Jiang Z Nat Commun. 2024; 15(1):4563.

PMID: 38811663 PMC: 11137010. DOI: 10.1038/s41467-024-48982-y.

Maprotiline ameliorates isoflurane-induced microglial activation via regulating triggering receptor expressed in myeloid cells 2 (TREM2).

Hu R, He Y, Chen Z Bioengineered. 2021; 12(2):12332-12344.

PMID: 34895041 PMC: 8810129. DOI: 10.1080/21655979.2021.2000740.

Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats.

Minaiyan M, Hajhashemi V, Rabbani M, Fattahian E, Mahzouni P Int Sch Res Notices. 2016; 2014:359841.

PMID: 27355055 PMC: 4897575. DOI: 10.1155/2014/359841.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Zhou S Clin Pharmacokinet. 2009; 48(12):761-804.

PMID: 19902987 DOI: 10.2165/11318070-000000000-00000.

References

Daneel A, Leigh W . Letter: Side-effects of maprotiline. S Afr Med J. 1974; 48(48):2009. View

Johnson N, Copeland G, Clarke S . Severe neutropenia and urticaria with antidepressant therapy. Lancet. 1976; 2(7999):1357. DOI: 10.1016/s0140-6736(76)92006-7. View

Matussek N, Aarons M . [Effect of single and repeated administration of maprotiline and its relation to plasma level in healthy test and subjects]. Arzneimittelforschung. 1974; 24(8):1107-11. View

Shibuya T, Matsuda H, Endo T, Chen P, Sato K, Nishimori T . Pharmacological studies of drug action on CNS, with special reference to effects of maprotiline. Int J Clin Pharmacol Biopharm. 1975; 11(3):192-204. View

Baltzer V, Delini-Stula A, BEIN H . [Pharmacological research on maprotiline a new drug with antidepressive effects]. Boll Chim Farm. 1973; 112(9):601-19. View

Michot F, Glaus L, JACK D, Theobald W . [Anticoagulant efficacy of Sintrom and blood concentration of Ludiomil on simultaneous administration of the two preparations]. Med Klin. 1975; 70(14):626-9. View

IMMICH H, ECKMANN F, Neumann H, SCHAPPERLE O, Schwarz H, Tempel H . [Basic problems in clinical testing of antidepressive drugs]. Arzneimittelforschung. 1971; 21(5):644-9. View

Jacobs D, Hutchison R . Letter: Side-effects of maprotiline. S Afr Med J. 1974; 48(49):2052. View

Lehmann H, Pecknold J, Ban T, Orbach L . A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients. Curr Ther Res Clin Exp. 1976; 19(4):463-8. View

10.

Coppen A, Gupta R, Montgomery S, Ghose K, Bailey J, Burns B . Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry. 1976; 129:342-5. DOI: 10.1192/bjp.129.4.342. View

11.

Benesova O, KASALICKY B, METYSOVA J . Some pharmacological effects of tetracyclic thymoleptic maprotiline in comparison with tricyclic antidepressants. Act Nerv Super (Praha). 1973; 15(2):107-8. View

12.

Szeless S, Kleinberger G, KOTZAUREK R, Pall H, Pichler M, Raberger G . [Fatal self-poisoning with the tetracyclic antidepressive drug, ludiomil (author's transl)]. Wien Klin Wochenschr. 1975; 87(7):254-8. View

13.

Hess R, Diener R, Fritz H, Pericin C, Heywood R, Newman A . [Toxicity and effects on animal reproduction of a new antidepressive agent, maprotiline (Ludiomil)]. Boll Chim Farm. 1973; 112(11):782-91. View

14.

Lauritsen B, Madsen H . A multinational, double-blind trial with a new antidepressant maprotiline (Ludiomil) and amitriptyline. Acta Psychiatr Scand. 1974; 50(2):192-201. DOI: 10.1111/j.1600-0447.1974.tb08208.x. View

15.

Elwan O, Taher Y, Allam M, Hassan M . A comparative study of antidepressants in the treatment of depressive states. J Int Med Res. 1976; 4(3):202-10. DOI: 10.1177/030006057600400309. View

16.

Kay N, Davies B . A controlled trial of maprotiline (Ludiomil) and amitriptyline in general practice. Med J Aust. 1974; 1(18):704-5. DOI: 10.5694/j.1326-5377.1974.tb93257.x. View

17.

Bruck J, Ogris E, Tschabitscher H . [Xerostomia and asalia due to psychopharmacologic therapy and their treatment with TPMP (trithioparamethoxyphenylpropen)]. Wien Med Wochenschr. 1974; 124(33-35):495-500. View

18.

Nieto Gomez D, Perez Rincon H . [A new antidepressive agent: C 34,276-Ba or maprotyline, 1st tetracyclic thymoanaleptic. Clinical study]. Prensa Med Mex. 1973; 38(11):429-34. View

19.

Waldmeier P, Baumann P, Greengrass P, Maitre L . Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover. Postgrad Med J. 1976; 52(3 suppl):33-9. View

20.

Singh A, Saxena B, Gent M, Nelson H . Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study. Curr Ther Res Clin Exp. 1976; 19(4):451-62. View